The probe is directed at all CAR-Ts currently ... positive lymphoma – in patients who had received both types of CAR-T therapy. The regulator highlighted the products by name, including Bristol- ...

When the symptoms and inflammation are not brought under control, they can cause organ damage. Like other cell therapies, CAR T cell therapy uses a modified cell either from the patient or from a ...

An interview with Anusha Kalbasi, MD, a radiation oncologist who studies CAR-T therapy to treat advanced melanoma, a type of ...

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new ...

Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a “smart drug” or “living drug,” CAR-T cell therapy relies on ...

Related False positive mammograms lead many women to stop getting scans As September puts focus on ovarian cancer, experts ...

CAR-T Therapy Won't Raise Odds for a Second Cancer, Study Finds By Ernie Mundell HealthDay Reporter WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- Contrary to a warning placed on labels for CART-T ...

We preselected all newsletters you had before unsubscribing.

T-cell exhaustion causes relapse in many patients within a year of receiving CAR-T cell therapy. In search of new solutions, Dr. Kenderian's team analyzed pre-infusion CAR-T cells from patients ...

According to the American Cancer Society, in CAR-T therapy, immune system T-cells "are taken from the patient's blood and are changed in the lab by adding a gene for a receptor (called a ...

Overall, 5.8% of patients developed the new cancers. Four of the trials compared outcomes for patients who received CAR-T therapy versus standard regimens. Rates of secondary cancers were similar ...